All Stories

  1. MUC5B rs35705950 Promoter Variant Is Associated with Usual Interstitial Pneumonia in Patients with Antisynthetase Syndrome
  2. Variants rs3804099 and rs3804100 in the TLR2 Gene Induce Different Profiles of TLR-2 Expression and Cytokines in Response to Spike of SARS-CoV-2
  3. Tongue Tuberculosis as a Complication of Pott’s Disease in a Patient on Systemic Steroid Therapy without Pulmonary Tuberculosis
  4. Matrix metalloprotease-7 is associated with post-COVID persistent lung abnormalities.
  5. The Immune Response of OAS1, IRF9, and IFI6 Genes in the Pathogenesis of COVID-19
  6. HLA-G14-bp variant is associated with exercise-induced oxygen desaturation in the post-COVID-19 condition
  7. The type 2 inflammatory response favors recognition of tumor antigens by IgE in breast cancer
  8. Variant rs4986790 of toll-like receptor 4 affects the signaling and induces cell dysfunction in patients with severe COVID-19
  9. Single-Nucleotide Variants in PADI2 and PADI4 and Ancestry Informative Markers in Interstitial Lung Disease and Rheumatoid Arthritis among a Mexican Mestizo Population
  10. Peptidyl Arginine Deiminases in Chronic Diseases: A Focus on Rheumatoid Arthritis and Interstitial Lung Disease
  11. Changes in lifestyle and physical and mental health related to long-confinement due COVID-19: a study during the first and second pandemic waves in Mexico and Chile
  12. Participation of Single-Nucleotide Variants in IFNAR1 and IFNAR2 in the Immune Response against SARS-CoV-2 Infection: A Systematic Review
  13. Single-Nucleotide Variants in PADI2 and PADI4 and Ancestry Informative Markers in Interstitial Lung Disease and Rheumatoid Arthritis among a Mexican Mestizo Population
  14. Molecular Factors in PAD2 (PADI2) and PAD4 (PADI4) Are Associated with Interstitial Lung Disease Susceptibility in Rheumatoid Arthritis Patients
  15. Lung Function and Asthma Clinical Control in N-ERD Patients, Three-Year Follow-Up in the Context of Real-World Evidence
  16. High Expression Levels of miR-21-5p in Younger Hospitalized COVID-19 Patients Are Associated with Mortality and Critical Disease
  17. The rs16969968 Tobacco Smoking-Related Single-Nucleotide Variant Is Associated with Clinical Markers in Patients with Severe COVID-19
  18. The ACE rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients
  19. Exploring the potential benefits of pharmacogenomics in chronic respiratory diseases
  20. Characterization of the lung microbiome and inflammatory cytokine levels in women exposed to environmental risk factors: A pilot study
  21. Serum Levels of IFABP2 and Differences in Lactobacillus and Porphyromonas gingivalis Abundance on Gut Microbiota Are Associated with Poor Therapeutic Response in Rheumatoid Arthritis: A Pilot Study
  22. SNPs Sets in Codifying Genes for Xenobiotics-Processing Enzymes Are Associated with COPD Secondary to Biomass-Burning Smoke
  23. Enhanced Activity of NLRP3 Inflammasome in the Lung of Patients with Anti-Synthetase Syndrome
  24. Current pharmacogenomic recommendations in chronic respiratory diseases: Is there a biomarker ready for clinical implementation?
  25. The HLA-DRB1*07 Allele Is Associated with Interstitial Lung Abnormalities (ILA) and Subpleural Location in a Mexican Mestizo Population
  26. Clinical and microbiological characteristics and inflammatory profile during an exacerbation of COPD due to biomass exposure. A comparison with COPD due to tobacco exposure
  27. COVID-19 Survivor Patients Carrying the Rs35705950 Risk Allele in MUC5B Have Higher Plasma Levels of Mucin 5B
  28. Interstitial lung disease progression in patients with Anti-aminoacyl Transfer-RNA-Synthetase Autoantibodies is characterized by higher levels of sCD163.
  29. SERPINE1 rs6092 Variant Is Related to Plasma Coagulation Proteins in Patients with Severe COVID-19 from a Tertiary Care Hospital
  30. TNFRSF1B and TNF variants are associated with differences in soluble TNF receptors' levels in patients with severe COVID-19
  31. Circulating Levels of PD-L1, TIM-3 and MMP-7 Are Promising Biomarkers to Differentiate COVID-19 Patients That Require Invasive Mechanical Ventilation
  32. CD4+/IL‑4+ lymphocytes of the lamina propria and substance P promote colonic protection during acute stress
  33. Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2
  34. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression
  35. Hypomethylation of AHRR (cg05575921) Is Related to Smoking Status in the Mexican Mestizo Population
  36. Cigarette Smoking Alters the Expression of Circulating microRNAs and Its Potential Diagnostic Value in Female Lung Cancer Patients
  37. Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
  38. Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality
  39. PADI2 Polymorphisms Are Significantly Associated With Rheumatoid Arthritis, Autoantibodies Serologic Status and Joint Damage in Women from Southern Mexico
  40. Protective Role of Genetic Variants in HSP90 Genes-Complex in COPD Secondary to Biomass-Burning Smoke Exposure and Non-Severe COPD Forms in Tobacco Smoking Subjects
  41. The “Slow Horse Racing Effect” on Lung Function in Adult Life in Chronic Obstructive Pulmonary Disease Associated to Biomass Exposure
  42. Molecular analysis of phenotypic interactions of asthma
  43. Genetic Variants in Smoking-Related Genes in Two Smoking Cessation Programs: A Cross-Sectional Study
  44. Clinical Markers of Chronic Hypoxemia in Respiratory Patients Residing at Moderate Altitude
  45. Lung Damage Caused by Heated Tobacco Products and Electronic Nicotine Delivery Systems: A Systematic Review
  46. Multidrug-resistant tuberculosis patients expressing the HLA-DRB1*04 allele, and after treatment they show a low frequency of HLA-II+ monocytes and a chronic systemic inflammation
  47. Genetics Insight for COVID-19 Susceptibility and Severity: A Review
  48. Genetic Factors Associated with COPD Depend on the Ancestral Caucasian/Amerindian Component in the Mexican Population
  49. Pharmacogenetics Approach for the Improvement of COVID-19 Treatment
  50. Single Nucleotide Polymorphism in the IL17A Gene Is Associated with Interstitial Lung Disease Positive to Anti-Jo1 Antisynthetase Autoantibodies
  51. Role of the Host Genetic Susceptibility to 2009 Pandemic Influenza A H1N1
  52. Genetic Susceptibility to Antisynthetase Syndrome Associated With Single-Nucleotide Variants in the IL1B Gene That Lead Variation in IL-1β Serum Levels
  53. Polymorphisms in Processing and Antigen Presentation-Related Genes and Their Association with Host Susceptibility to Influenza A/H1N1 2009 Pandemic in a Mexican Mestizo Population
  54. The SNP rs13147758 in the HHIP Gene Is Associated With COPD Susceptibility, Serum, and Sputum Protein Levels in Smokers
  55. Participation of HHIP Gene Variants in COPD Susceptibility, Lung Function, and Serum and Sputum Protein Levels in Women Exposed to Biomass-Burning Smoke
  56. Lung Microbiome Participation in Local Immune Response Regulation in Respiratory Diseases
  57. Methotrexate and rheumatoid arthritis associated interstitial lung disease
  58. Smoke exposure from chronic biomass burning induces distinct accumulative systemic inflammatory cytokine alterations compared to tobacco smoking in healthy women
  59. Anti-Aminoacyl Transfer-RNA-Synthetases (Anti-tRNA) Autoantibodies Associated with Interstitial Lung Disease: Pulmonary Disease Progression has a Persistent Elevation of the Th17 Cytokine Profile
  60. HLA in hypersensitivity pneumonitis patients positives to autoantibodies
  61. Heterozygous Genotype rs17580 AT (PiS) in SERPINA1 is Associated with COPD Secondary to Biomass-Burning and Tobacco Smoking: A Case–Control and Populational Study
  62. Single Nucleotide and Copy-Number Variants in IL4 and IL13 Are Not Associated with Asthma Susceptibility or Inflammatory Markers: A Case-Control Study in a Mexican-Mestizo Population
  63. Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease
  64. Genetic variants in IL17A and serum levels of IL-17A are associated with COPD related to tobacco smoking and biomass burning
  65. HLA Allele and Haplotype Frequencies in Three Urban Mexican Populations: Genetic Diversity for the Approach of Genomic Medicine
  66. Effect of SNPs in HSP Family Genes, Variation in the mRNA and Intracellular Hsp Levels in COPD Secondary to Tobacco Smoking and Biomass-Burning Smoke
  67. IL10 rs1800872 Is Associated with Non-Steroidal Anti-Inflammatory Drugs Exacerbated Respiratory Disease in Mexican-Mestizo Patients
  68. The VNTR 48 bp Polymorphism in the DRD4 Gene Is Associated with Higher Tobacco Smoking in Male Mexican Mestizo Smokers with and without COPD
  69. Haplotype in SERPINA1 (AAT) Is Associated with Reduced Risk for COPD in a Mexican Mestizo Population
  70. Participation of the miR-22-HDAC4-DLCO Axis in Patients with COPD by Tobacco and Biomass
  71. miR-34a in serum is involved in mild-to-moderate COPD in women exposed to biomass smoke
  72. MMP2 Polymorphism Affects Plasma Matrix Metalloproteinase (MMP)-2 Levels, and Correlates with the Decline in Lung Function in Hypersensitivity Pneumonitis Positive to Autoantibodies Patients.
  73. Evolution of Pulmonary Function in a Cohort of Patients with Interstitial Lung Disease and Positive for Antisynthetase Antibodies
  74. Corrigendum to “Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer” [Crit. Rev. Oncol. Hematol. 137, May (2019) 57–83]
  75. Data on genotype frequency for SNPs associated to age of smoking onset and successful smoking cessation treatment
  76. Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer
  77. A Mobile Smoking Cessation Intervention for Mexico (Vive sin Tabaco... ¡Decídete!): Single-Arm Pilot Study
  78. Genetic variants as risk factors for cigarette smoking at an early age and relapse to smoking cessation treatment: A pilot study
  79. Role of Genetic Susceptibility in Nicotine Addiction and Chronic Obstructive Pulmonary Disease
  80. Allergic sensitization increases the amount of extracellular ATP hydrolyzed by guinea pig leukocytes
  81. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
  82. Influence of proinflammatory cytokine gene polymorphisms on the risk of COPD and the levels of plasma protein
  83. A Mobile Smoking Cessation Intervention for Mexico (Vive sin Tabaco... ¡Decídete!): Single-Arm Pilot Study (Preprint)
  84. Genetic variant in MMP2 increases the risk to develop autoantibodies in patients with Hypersensitivity Pneumonitis
  85. HTR2A genetic variants as risk factors for cigarette smoking at an early age and relapse to smoking cessation treatment.
  86. HLA class II alleles and haplotypes are associated to the presence autoantibodies and mortality in Hypersensitivity Pneumonitis patients.
  87. MS4A2-rs573790 Is Associated With Aspirin-Exacerbated Respiratory Disease: Replicative Study Using a Candidate Gene Strategy
  88. Chronic infection with Mycobacterium lepraemurium induces alterations in the hippocampus associated with memory loss
  89. OP0284 Muc5b promoter variant rs35705950 is a risk factor for rheumatoid arthritis – interstitial lung disease
  90. Prevalence of COPD and respiratory symptoms associated with biomass smoke exposure in a suburban area
  91. TNF promoter polymorphisms are associated with genetic susceptibility in COPD secondary to tobacco smoking and biomass burning
  92. Genetic polymorphisms and their involvement in the regulation of the inflammatory response in asthma and COPD
  93. Class I HLA alleles are associated with influenza A H1N1 susceptibility.
  94. Single nucleotide polymorphisms in TNF are associated with susceptibility to aspirin-exacerbated respiratory disease but not to cytokine levels: a study in Mexican mestizo population
  95. Data on polymorphisms in CYP2A6 associated to risk and predispose to smoking related variables
  96. Physiopathology and genetics in aspirin-exacerbated respiratory disease
  97. NTPDase activity in circulatory eosinophils from patients with allergic asthma
  98. Genetic polymorphisms in CYP2A6 are associated with a risk of cigarette smoking and predispose to smoking at younger ages
  99. Comparison of HSP mRNA relative levels in sputum of COPD patients and subjects exposed to wood smoke and/or cigarette smoke
  100. Heterozygous genotype rs17580 AT (PiS) in SERPINA1 is associated to COPD secondary to biomass and tobacco smoke
  101. Mediadores de la respuesta inflamatoria en asma y su relación con obesidad
  102. Participation of Th17 mediators in COPD exacerbations
  103. Polymorphisms in HTR2A and DRD4 Predispose to Smoking and Smoking Quantity
  104. SNPs in NRXN1 and CHRNA5 are associated to smoking and regulation of GABAergic and glutamatergic pathways
  105. Genetic Variants inIL6RandADAM19are Associated with COPD Severity in a Mexican Mestizo Population
  106. Association of TRPM3 Polymorphism (rs10780946) and Aspirin-Exacerbated Respiratory Disease (AERD)
  107. TNF, IL6, and IL1B Polymorphisms Are Associated with Severe Influenza A (H1N1) Virus Infection in the Mexican Population
  108. Chronic obstructive pulmonary disease induced by exposure to biomass smoke is associated with a Th2 cytokine production profile
  109. Prevalence of chronic obstructive pulmonary disease in asymptomatic smokers
  110. Genetic polymorphisms of matrix metalloproteinases and protein levels in chronic obstructive pulmonary disease in a Mexican population
  111. Genetic variants inNRXN1,CHRNA3,CHRNA5andCHRNB4are associated with smoking and increased consumption of cigarettes per day in a Mexican mestizo population
  112. TNFpromoter polymorphisms are associated with susceptibility and increased severity in secondary to tobacco and biomass smoke COPD in Mexican population
  113. Identification of genetic variants in the TNF promoter associated with COPD secondary to tobacco smoking and its severity
  114. Prevalence of Alpha-1 Antitrypsin High-risk Variants in Mexican Mestizo Population and Their Association With Lung Function Values
  115. Prevalencia de variantes de alto riesgo de alfa-1 antitripsina en población mestiza mexicana y su relación con los valores de la función pulmonar
  116. HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients
  117. Glucose and glutamine metabolism control by APC and SCF during the G1-to-S phase transition of the cell cycle
  118. Genetic susceptibility to multicase hypersensitivity pneumonitis is associated with the TNF-238 GG genotype of the promoter region and HLA-DRB1*04 bearing HLA haplotypes
  119. HLA Class II Alleles in the Otomi Population of the Mezquital Valley: A Genetic Approach to the History of Interethnic Migrations in the Mexican Central Plateau
  120. Genetic polymorphism of tumor necrosis factor promoter region and susceptibility to develop Hodgkin lymphoma in a Mexican population
  121. Biochemical pathogenesis of aspirin exacerbated respiratory disease (AERD)
  122. Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCLpolymorphisms in Mexican population: a case–control study
  123. 288 IL1B but not IL8 Polymorphisms Are Increased in Aspirin Exacerbated Respiratory Disease Patients Versus Aspirin Tolerant Asthmatics
  124. The IL1B-511 Polymorphism (rs16944 AA Genotype) Is Increased in Aspirin-Exacerbated Respiratory Disease in Mexican Population
  125. Sleep, Fatigue, Depression, and Pain in Mexican Women With Systemic Lupus Erythematosus: An Exploratory Study
  126. PSMB8 (LMP7) but not PSMB9 (LMP2) gene polymorphisms are associated to pigeon breeder's hypersensitivity pneumonitis
  127. MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility
  128. Major histocompatibility complex and alveolar epithelial apoptosis in idiopathic pulmonary fibrosis
  129. Major Histocompatibility Complex and Tumor Necrosis Factor- α Polymorphisms in Pigeon Breeder's Disease